Magnetic Resonance Imaging and Other Imaging Modalities in Diagnostic and Tumor Response Evaluation

Kim, 2009, Locally advanced rectal cancer: Added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy, Radiology, 253, 116, 10.1148/radiol.2532090027 Lambregts, 2011, Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: A multicenter study, Ann Surg Oncol, 18, 2224, 10.1245/s10434-011-1607-5 van der Paardt, 2013, Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: A systematic review and meta-analysis, Radiology, 269, 101, 10.1148/radiol.13122833 Curvo-Semedo, 2011, Rectal cancer: Assessment of complete response to preoperative combined radiation therapy with chemotherapy—Conventional MR volumetry versus diffusion-weighted MR imaging, Radiology, 260, 734, 10.1148/radiol.11102467 Ha, 2013, Locally advanced rectal cancer: Diffusion-weighted MR tumor volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy, Eur Radiol, 23, 3345, 10.1007/s00330-013-2936-5 Carbone, 2012, Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: A preliminary report, Radiol Med, 117, 1112, 10.1007/s11547-012-0829-3 Lambregts, 2015, MRI and diffusion-weighted mri volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: A bi-institutional validation study, Ann Surg, 262, 1034, 10.1097/SLA.0000000000000909 Sun, 2010, Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging, Radiology, 254, 170, 10.1148/radiol.2541082230 Lambrecht, 2012, Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: Preliminary results, Int J Radiat Oncol Biol Phys, 82, 863, 10.1016/j.ijrobp.2010.12.063 Intven, 2013, in locally advanced rectal cancer: Pathological response prediction after neo-adjuvant radiochemotherapy, Strahlenther Onkol, 189, 117, 10.1007/s00066-012-0270-5 Curvo-Semedo, 2012, Diffusion-weighted MRI in rectal cancer: Apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness, J Magn Reson Imaging, 35, 1365, 10.1002/jmri.23589 Sun, 2014, Apparent diffusion coefficient (ADC) value: A potential imaging biomarker that reflects the biological features of rectal cancer, PLoS One, 9, e109371, 10.1371/journal.pone.0109371 Donati, 2014, Diffusion-weighted MR imaging of upper abdominal organs: Field strength and intervendor variability of apparent diffusion coefficients, Radiology, 270, 454, 10.1148/radiol.13130819 Lambregts, 2011, Tumor ADC measurements in rectal cancer: Effect of ROI methods on ADC values and interobserver variability, Eur Radiol, 21, 2567, 10.1007/s00330-011-2220-5 Tong, 2015, Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer, J Magn Reson Imaging, 42, 376, 10.1002/jmri.24835 Intven, 2015, Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer, Acta Oncol, 1 George, 2001, Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer, Br J Surg, 88, 1628, 10.1046/j.0007-1323.2001.01947.x Intven, 2015, Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation, J Magn Reson Imaging, 41, 1646, 10.1002/jmri.24718 Martens, 2015, Can perfusion MRI predict response to preoperative treatment in rectal cancer?, Radiother Oncol, 114, 218, 10.1016/j.radonc.2014.11.044 Gollub, 2012, Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer, Eur Radiol, 22, 821, 10.1007/s00330-011-2321-1 Kim, 2014, Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer, J Magn Reson Imaging, 40, 730, 10.1002/jmri.24387 Petrillo, 2015, Standardized index of shape (SIS): A quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC, Eur Radiol, 25, 1935, 10.1007/s00330-014-3581-3 Yao, 2011, Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features, Radiol Med, 116, 366, 10.1007/s11547-011-0628-2 Yeo, 2015, Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results, J Magn Reson Imaging, 41, 474, 10.1002/jmri.24541 Zhang, 2008, 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: Correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis, J Magn Reson Imaging, 27, 1309, 10.1002/jmri.21378 Atkin, 2006, Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis, Br J Surg, 93, 992, 10.1002/bjs.5352 Kim, 2013, Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: Correlation with microvascular density and vascular endothelial growth factor expression, Korean J Radiol, 14, 878, 10.3348/kjr.2013.14.6.878 Lollert, 2014, Rectal cancer: Dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression, J Magn Reson Imaging, 39, 1436, 10.1002/jmri.24301 Martens, 2015, Magnetization transfer imaging to assess tumor response after chemoradiotherapy in rectal cancer, Eur Radiol, 26, 390, 10.1007/s00330-015-3856-3 Kim, 2014, Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: A preliminary experience, Eur Radiol, 24, 1514, 10.1007/s00330-014-3167-0 Dzik-Jurasz, 2002, Human rectal adenocarcinoma: Demonstration of 1H-MR spectra in vivo at 1.5T, Magn Reson Med, 47, 809, 10.1002/mrm.10108 Li, 2014, 18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: A meta-analysis, Ann Nucl Med, 28, 436, 10.1007/s12149-014-0837-6 Zhang, 2012, 18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: A meta-analysis, Int J Cancer, 131, 2604, 10.1002/ijc.27557 Krug, 2013, A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation, Colorectal Dis, 15, e627, 10.1111/codi.12295 Nakamoto, 2002, Factors related to positive PET findings in patients with high CEA levels, J Nucl Med, 5, 26 Muijs, 2011, 18F-FLT-PET for detection of rectal cancer, Radiother Oncol, 98, 357, 10.1016/j.radonc.2010.12.008 Wieder, 2007, PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer, Eur J Nucl Med Mol Imaging, 34, 878, 10.1007/s00259-006-0292-2 Kizaka-Kondoh, 2009, Significance of nitromidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia, Cancer Sci, 100, 1366, 10.1111/j.1349-7006.2009.01195.x Dietz, 2008, Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: A pilot study, Dis Colon Rectum, 51, 1641, 10.1007/s10350-008-9420-3 Lamberts, 2015, Antibody positron emission tomography imaging in anticancer drug development, J Clin Oncol, 33, 1491, 10.1200/JCO.2014.57.8278 Makris, 2015, PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab, J Nucl Med, 56, 249, 10.2967/jnumed.114.147819 Schoffelen, 2012, Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: A new sensitive detection method, Eur J Nucl Med Mol Imaging Res, 2, 5 Nittka, 2014, Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice, PLoS One, 9, e106921, 10.1371/journal.pone.0106921